Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2000Journal of Clinical Oncology

Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPhilip BonomiRush University Medical CenterKKKyungMann KimUniversity of Wisconsin–MadisonDFDiane L. FaircloughColorado School of Public Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bonomi et al. (2000) studied this question.

synapsesocial.com/papers/6a0ccd4d9d761985b14a4dbdhttps://doi.org/10.1200/jco.2000.18.3.623
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials1998 · 121 citations
  2. 2Cancer statistics, 19991999 · 3,123 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 39,556 citations
  4. 4Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results1993 · 339 citations
  5. 5Toxicity and response criteria of the Eastern Cooperative Oncology Group1982 · 11,821 citations